2011
Porter DW, Thompson FM, Berthoud TK, Hutchings CL, Andrews L, Biswas S, Poulton I, Prieur E, Correa S, Rowland R, Lang T, Williams J, Gilbert SC, Sinden RE, Todryk S, Hill AV. A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine. Vaccine 2011 Oct 6;29(43):7514-22. Epub 2011 16 Apr. (FP9 PP and MVA PP)
Mark J. Geels, Egeruan Babatunde Imoukhuede, Nathalie Imbault, Harry van Schooten, Terry McWade, Marita Troye-Blomberg, Roland Dobbelaer, Alister G. Craig, Odile Leroy. European Vaccine Initiative: lessons from developing malaria vaccines.
Expert Reviews Vaccines 2011, vol. 10 (12) 1697 - 1708
Regitze L Thogersen, Anthony A Holder, Adrian VS Hill, David E Arnot, Egeruan B Imoukhuede, Odile Leroy. Comparative decline in funding of European Commission malaria vaccine projects: what next for the European scientists working in this field?
Malaria Journal 2011, 10:255 doi:10.1186/1475-2875-10-255
Sabine Bélard, Saadou Issifou, Aurore B. Hounkpatin, Frieder Schaumburg, Ulysse Ateba Ngoa, Meral Esen, Rolf Fendel, Pablo Martinez de Salazar, Raymund E. Mürbeth, Paul Milligan, Nathalie Imbault, Egeruan Babatunde Imoukhuede, Michael Theisen, Søren Jepsen, Ramadhani A. Noor, Brenda Okech, Peter G. Kremsner, Benjamin Mordmüller. A Randomised Controlled Phase Ib Trial of the Malaria Vaccine Candidate GMZ2 in African Children.
PLoS One, July 2011, vol. 6, issue 7
Agnes Kisser, Ulrich Heininger, Vasee S. Moorthy, Bartholomew D. Akanmori and Odile Leroy: Addressing the needs and gaps in safety assessment of vaccines during clinical trials in resource limited countries.
Vaccine (Epub 16 April 2011), doi:10.1016/j.vaccine.2011.03.008
OPTIMALVAC Consortium: Towards validated assays for key immunological outcomes
Vaccine (Epub 4 Feb 2011), DOI: doi:10.1016/j.vaccine.2011.01.070